• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000年至2008年嗜铬细胞瘤的假阳性检测结果。

False positive test results for pheochromocytoma from 2000 to 2008.

作者信息

Yu R, Wei M

机构信息

Division of Endocrinology, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

出版信息

Exp Clin Endocrinol Diabetes. 2010 Oct;118(9):577-85. doi: 10.1055/s-0029-1237699. Epub 2009 Dec 8.

DOI:10.1055/s-0029-1237699
PMID:19998239
Abstract

Testing for pheochromocytoma becomes more frequent in clinical practice. False positive test results may cause patient anxiety and unnecessary imaging studies. The data on false positive results for pheochromocytoma in routine clinical practice are lacking. To examine the prevalence of false positive results and to reveal the clinical features and laboratory tests of patients with markedly elevated but false positive test results, a database of tests for pheochromocytoma at a large general hospital between 2000 and 2008 was reviewed. Of 1,896 patients tested, 417 (22.0%) had at least one abnormal test result and 66 (3.5%) had markedly elevated results. 24 patients with markedly elevated but false positive results received 65 imaging studies and 1 adrenalectomy. The causes of the misleading results included physiological variations (33%), laboratory errors (29%), and drug interference with measurement (21%). The false positive rate of a markedly elevated result was lowest for vanillylmandelic acid (9%) and highest for urine metanephrines (50%) (p = 0.03). Nearly half of all test results were normal and 79% of patients had at least one normal result. Therefore false positive test results for pheochromocytoma are rather common. Markedly elevated but false positive test results can potentially be avoided by judicious selection of patients and tests. Pretest risk, physiological variations of catecholamine levels, laboratory errors, and drug interference should be considered in interpreting abnormal test results.

摘要

在临床实践中,嗜铬细胞瘤的检测变得更加频繁。假阳性检测结果可能会导致患者焦虑以及不必要的影像学检查。目前缺乏关于常规临床实践中嗜铬细胞瘤假阳性结果的数据。为了检查假阳性结果的发生率,并揭示检测结果显著升高但为假阳性的患者的临床特征和实验室检查情况,我们回顾了一家大型综合医院在2000年至2008年间的嗜铬细胞瘤检测数据库。在1896名接受检测的患者中,417名(22.0%)至少有一项检测结果异常,66名(3.5%)检测结果显著升高。24名检测结果显著升高但为假阳性的患者接受了65次影像学检查和1次肾上腺切除术。导致结果误导的原因包括生理变异(33%)、实验室误差(29%)以及药物对测量的干扰(21%)。香草扁桃酸检测结果显著升高时的假阳性率最低(9%),尿甲氧基肾上腺素的假阳性率最高(50%)(p = 0.03)。几乎所有检测结果的一半是正常的,79%的患者至少有一项正常结果。因此,嗜铬细胞瘤的假阳性检测结果相当常见。通过明智地选择患者和检测方法,有可能避免检测结果显著升高但为假阳性的情况。在解释异常检测结果时,应考虑检测前风险、儿茶酚胺水平的生理变异、实验室误差和药物干扰。

相似文献

1
False positive test results for pheochromocytoma from 2000 to 2008.2000年至2008年嗜铬细胞瘤的假阳性检测结果。
Exp Clin Endocrinol Diabetes. 2010 Oct;118(9):577-85. doi: 10.1055/s-0029-1237699. Epub 2009 Dec 8.
2
[Diagnostic significance of the clonidine suppression test in suspected pheochromocytoma].[可乐定抑制试验在疑似嗜铬细胞瘤中的诊断意义]
Dtsch Med Wochenschr. 1988 Jan 29;113(4):130-4. doi: 10.1055/s-2008-1067606.
3
[Preoperative diagnostics in patients with adrenal tumors].[肾上腺肿瘤患者的术前诊断]
Folia Med Cracov. 2005;46(1-2):89-97.
4
Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients.游离血浆间甲肾上腺素作为低风险患者嗜铬细胞瘤筛查试验。
J Hypertens. 2007 Jul;25(7):1427-31. doi: 10.1097/HJH.0b013e32813aeb5a.
5
[Preoperative diagnosis of suspected pheochromocytoma--retrospective assessment of diagnostic criteria].[疑似嗜铬细胞瘤的术前诊断——诊断标准的回顾性评估]
Acta Med Austriaca. 1988;15(4):106-8.
6
[Personal experience in diagnosis and localization of pheochromocytoma].[嗜铬细胞瘤诊断与定位的个人经验]
Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:14-9.
7
Pheochromocytoma with elevated metanephrines as the only biochemical finding.以间甲肾上腺素升高为唯一生化表现的嗜铬细胞瘤。
J La State Med Soc. 1996 Dec;148(12):535-8.
8
Clinical experience with incidentally discovered pheochromocytoma.偶然发现的嗜铬细胞瘤的临床经验。
J Urol. 1997 May;157(5):1566-8.
9
[Evaluation of the usefulness of certain localization methods in diagnosis of pheochromocytoma].[某些定位方法在嗜铬细胞瘤诊断中的有用性评估]
Pol Tyg Lek. 1991;46(35-36):639-40.
10
[Biological diagnosis of pheochromocytoma: impact of technological improvement].[嗜铬细胞瘤的生物学诊断:技术进步的影响]
Ann Biol Clin (Paris). 1993;51(10-11):835-65.

引用本文的文献

1
The clinical spectrum of adrenal ganglioneuromas extends from severe hypertension to an asymptomatic incidentaloma; two cases and mini review of literature.肾上腺神经节瘤的临床谱范围从严重高血压到无症状偶发瘤;两例病例及文献综述
Hormones (Athens). 2025 May 28. doi: 10.1007/s42000-025-00676-w.
2
Pitfalls in the Diagnostic Evaluation of Pheochromocytomas.嗜铬细胞瘤诊断评估中的陷阱
J Endocr Soc. 2024 May 8;8(6):bvae078. doi: 10.1210/jendso/bvae078. eCollection 2024 Apr 6.
3
False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
去甲肾上腺素再摄取阻滞与嗜铬细胞瘤假阳性结果相关。
Endocr Relat Cancer. 2023 Dec 1;31(1). doi: 10.1530/ERC-23-0063. Print 2024 Jan 1.
4
Paraganglioma in pregnancy, a mimic of preeclampsia: a case report.妊娠性副神经节瘤,子痫前期的模拟病例:一例报告。
J Med Case Rep. 2023 Apr 7;17(1):124. doi: 10.1186/s13256-023-03871-8.
5
The clinical utility of plasma and urine metanephrines in hypertensive emergency.血浆和尿甲氧基肾上腺素在高血压急症中的临床应用
Hormones (Athens). 2023 Mar;22(1):121-130. doi: 10.1007/s42000-022-00422-6. Epub 2023 Jan 4.
6
Is the Adrenal Incidentaloma Functionally Active? An Approach-To-The-Patient-Based Review.肾上腺偶发瘤是否具有功能活性?基于患者的评估方法综述。
J Clin Med. 2022 Jul 14;11(14):4064. doi: 10.3390/jcm11144064.
7
The Impact of SARS-Cov-2 Virus Infection on the Endocrine System.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染对内分泌系统的影响
J Endocr Soc. 2020 Jul 2;4(8):bvaa082. doi: 10.1210/jendso/bvaa082. eCollection 2020 Aug 1.
8
Case report of a phantom pheochromocytoma.病例报告:假性嗜铬细胞瘤
Biochem Med (Zagreb). 2020 Jun 15;30(2):021003. doi: 10.11613/BM.2020.021003.
9
Endocrine causes of hypertension in pregnancy.妊娠期高血压的内分泌病因
Gland Surg. 2020 Feb;9(1):69-79. doi: 10.21037/gs.2019.12.04.
10
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.来自 SSO 内分泌/头颈部疾病工作组的嗜铬细胞瘤和副神经节瘤更新。第 1 部分,共 2 部分:嗜铬细胞瘤和副神经节瘤发病机制和诊断的进展。
Ann Surg Oncol. 2020 May;27(5):1329-1337. doi: 10.1245/s10434-020-08220-3. Epub 2020 Feb 28.